Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Isabella Sofia Berglund-Brown, M.D.

Concepts (13)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Isabella Berglund-Brown's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Isabella Berglund-Brown has written about over time.
CpG Islands, 1 publications between 2022 and 2022, average publication date February 2022. DNA Methylation, 1 publications between 2022 and 2022, average publication date February 2022. Glioma, 1 publications between 2022 and 2022, average publication date February 2022. Head and Neck Neoplasms, 1 publications between 2022 and 2022, average publication date February 2022. Humans, 2 publications between 2022 and 2023, average publication date January 2023. Animals, 1 publications between 2023 and 2023, average publication date November 2023. Heart, 1 publications between 2023 and 2023, average publication date November 2023. Heart Defects, Congenital, 1 publications between 2023 and 2023, average publication date November 2023. Histones, 1 publications between 2023 and 2023, average publication date November 2023. Mice, 1 publications between 2023 and 2023, average publication date November 2023. Ubiquitination, 1 publications between 2023 and 2023, average publication date November 2023. Ubiquitin-Conjugating Enzymes, 1 publications between 2023 and 2023, average publication date November 2023. Ubiquitin-Protein Ligases, 1 publications between 2023 and 2023, average publication date November 2023.

To see the data from this visualization as text, click here.
Berglund-Brown's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (13)
Explore
_
Co-Authors (5)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.